• March 30, 2022 1:15 am
  • Alaska

Developing a novel, safe drug to prevent heart attacks, strokes, and liver transplants from NASH






$317K+ ((($317,066+))) 

157+ Investors // 1New

$100 Min. Investment

$20M Valuation


@John R Hume  


@Manosh k Sinha


✔CEO designed trials for Vascepa®, which reduces heart attack and stroke risk for high triglycerides.

✔Awarded $700k from Dutch government to perform more studies on our drug Corvida™’s potential.

✔Results of Corvida™’s affect on genes associated with atherosclerosis due in 2022.


✔Funds raised will lead to PreIND meetings with the FDA to ensure acceptability of human trials.

✔Corvida™’s components are designated GRAS (Generally Regarded as Safe) by the FDA.

✔Corvida™ is protected by patents in the US and Japan and are owned by the company.

✔This is an opportunity for you to impact global health and potentially realise significant financial gains.




  • Category : Domestic, Personal & IT
  • Service Type : Home Services